Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02978716
Brief Title: Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

First Submitted : November 18, 2016
First Submitted that Met QC Criteria : November 28, 2016
First Posted : December 1, 2016 (Estimate)

Results First Submitted : January 6, 2022
Results First Posted with QC Comments : February 4, 2022
Results First Submitted that Met QC Criteria : February 24, 2022
Results First Posted : March 23, 2022

Certification/Extension First Submitted : July 18, 2019
Certification/Extension First Submitted that Met QC Criteria : February 24, 2022
Certification/Extension First Posted : March 23, 2022

Last Update Submitted that Met QC Criteria : February 24, 2022
Last Update Posted : March 23, 2022